Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: Results of additional and long-term follow- up: Silicone study report 11

Archives of Ophthalmology

Volumn 115, Issue 3, 1997, Pages 335-344

  Abrams, Gary W ^a   Azen, Stanley P ^b,e   McCuen II, Brooks W ^c   Flynn Jr , Harry W ^d   Lai, Mei Ying ^b   Ryan, Stephen J ^b  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c DUKE UNIVERSITY EYE CENTER   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e CHP 218 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAFLUOROPROPANE; SILICONE OIL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMULSION; FEMALE; GLAUCOMA; HUMAN; KERATOPATHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; RETINA MACULA LUTEA; RISK FACTOR; TRABECULAR MESHWORK; VISUAL ACUITY; VISUAL IMPAIRMENT; VITRECTOMY; VITREORETINOPATHY;

EID: 0030968428     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1997.01100150337005     Document Type: Article

References (37)

1. The Silicone Study Group. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial: Silicone Study Report 1. Arch Ophthalmol. 1992;110:770-779.
2. The Silicone Study Group. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial: Silicone Study Report 2. Arch Ophthalmol. 1992;110:780-792.
3. McCuen BW, Azen SP, Stern W, et al. Vitrectomy with Silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results in group 1 versus group 2 (Silicone Study Report 3). Retina. 1993;13:279-284.
4. Barr CC, Lai MY, Lean JS, et al. Postoperative introcular pressure abnormalities in the Silicone Study (Silicone Study Report 4). Ophthalmology. 1993; 100:1629-1635.
5. Blumenkranz MS, Azen SP, Aaberg TM, et al. Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy (Silicone Study Report 5). Am J Ophthalmology. 1993;116:557-564.
6. Hutton WL, Lee MBF, Blumenkranz MS, et al. The effects of Silicone oil removal in the Silicone Study (Silicone Study Report 6). Arch Ophthalmol. 1994; 112:778-785.
7. Abrams GW, Azen SP, Barr CC, et al. The incidence of corneal abnormalties in the Silicone Study. Arch Ophthalmol. 1995;113:764-769.
8. Cox MS, Azen SP, Barr CC, et al. Macular pucker after succesful surgery for proliferative vitreoretinopathy (Silicone Study Report 8). Ophthalmology. 1995; 102:1884-1891.
9. Diddie KR, Azen SP, Freeman HM, et al. Anterior proliferative vitreoretinopathy in the Silicone Study (Silicone Study Report 10). Ophthalmology. 1996;107: 1092-1099.
10. Lean J, Azen SP, Lopez P, Qian D, Lai MY, McCuen B, for the Silicone Study Group. The prognostic utility of the Silicone Study classification system: Silicone Study Report 9. Arch Ophthalmol. 1996;114:286-292.
11. Azen SP, Boone DC, Barlow W, et al. Methods, statistical features, and baseline results of a standardized, multicentered ophthalmologic surgical trial: the Silicone Study. Control Clin Trials. 1991;12:438-455.
12. Watzke RC. Silicone retinopiesis for retinal detachment: a long-term clinical evaluation. Arch Ophthalmol. 1967;77:185-196.
13. Leaver PK, Grey RHB, Garner A. Silicone oil injection In the treatment of massive preretinal retraction, II. Br J Ophthalmol. 1979;63:361-367.
14. Okun E. Intravitreal surgery utilizing liquid Silicone: a long-term follow-up. Trans Pac Coast Oto-Ophthalmol Soc. 1968;49:141-159.
15. Cibis PA, Becker B, Okun E, Canaan S. The use of liquid Silicone in retinal detachment surgery. Arch Ophthalmol. 1962;68:590-599.
16. Beekhuis WH, van Rij G, Zivojnovic R. Silicone oil keratopathy: indications for keratoplasty. Br J Ophthalmol. 1985;69:247-253.
17. Cockerham WD, Schepens CL, Freeman HM. Silicone injection in retinal detachment. Arch Ophthalmol. 1970;83:704-712.
18. Lee PF, Donovan RH, Mukai N, Schepens CL, Freeman HM. Intravitreous injection of Silicone; an experimental study, I. Ann Ophthalmol. 1969;1:15-25.
19. Mukai N, Lee PF, Oguri M, Schepens CL. A long-term evaluation of silicone retinopathy in monkeys. Can J Ophthalmol. 1975;10:391-402.
20. Hanneken A, Michels RG. Vitrectomy and scleral buckling methods for proliferative vitreoretinopathy. Ophthalmology. 1988;95:865-869.
21. Glaser BM. Surgery for proliferative vitreoretinopathy. In: Ryan SJ, ed. Retina. 2nd ed. St Louis, Mo: Mosby-Year Book Inc; 1994:2265-2280.
22. Morse LS, McCuen BW. The use of Silicone oil in uveitis and hypotony. Retina. 1991;11:399-404.
23. Nguyen QH, Lloyd MA, Heuer DK, et al. Incidence and management of glaucoma after intravitreal Silicone oil injection for complicated retinal detachments. Ophthalmology. 1992;99:1520-1526.
24. Burk LL, Shields MB, Proia AD, McCuen BW. Intraocular pressure following intravitreal silicone oil injection. Ophthalmic Surg Lasers. 1988;19:565-569.
25. Riedel KG, Gabel VP, Neubauer L, Kampik A, Lund OE. Intravitreal silicone oil injection. Graefes Arch Clin Exp Ophthalmol. 1990;228:19-23.
26. Federman JL, Schubert HD. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology. 1988;95:870-876.
27. Nowack C, Lucke K, Laqua H. Removal of silicone oil in treatment of so-called emulsification glaucoma. Ophthalmologe. 1992;89:462-464.
28. Diekert JP, O'Connor PS, Schacklett DE, et al. Air travel and intraocular gas. Ophthalmology. 1986;93:642-645.
29. Hanscom TA, Diddie KR. Mountain travel and intraocular gas bubbles. Am J Ophthalmol. 1987;104:546.
30. Lincoff H, Weinberger D, Stergiu P. Air travel with intraocular gas, II: clinical considerations. Arch Ophthalmol. 1989;107:907-910.
31. Lean JS. Use of silicone oil as an additional technique in vitreoretinal surgery. In: Ryan SJ, ed. Retina. 2nd ed. St Louis, Mo: Mosby-Year Book Inc; 1994:2158-2159.
32. Lewis H, Burke JM, Abrams GW, Aaberg TM. Perisilicone proliferation after Vitrectomy for proliferative vitreoretinopathy. Ophthalmology. 1988;95:583-591.
33. Machemer R, Norton EWD. A new concept for vitreous surgery, III: indications and results. Am J Ophthalmol. 1972;74:1034-1056.
34. Machemer R. Massive periretinal proliferation: a logical approach to therapy. Trans Am Ophthalmol Soc. 1978;75:556-580.
35. Sternberg P Jr, Machemer R. Results of conventional vitreous surgery for proliferative vitreoretinopathy. Am J Ophthalmol. 1985;100:141-146.
36. Lewis H, Aaberg TM. Causes of failure after repeat vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol. 1991;111:15-19.
37. Lewis H, Aaberg TM, Abrams GW. Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol. 1991;11: 8-14.